Autologous cultured fibroblast cell therapy for treatment of stria alba

Read full text Summarise with VIRAT
Authors: Hanan S. Mohammed, Ghada Fathy Mohammed, Nashwa Nagy El-Khazragy, Norhan Khaled
Cited by: 0
References: 20

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: There is growing evidence that human autologous cultured fibroblast transplantation is a viable alternative therapy to prevent and reduce the structural alterations in aging skin. Striae alba (SA), the atrophic, white-stage manifestation of striae distensae, presents a significant cosmetic concern with limited treatment options. Emerging therapies suggest autologous cultured fibroblast transplantation may regenerate dermal structures through enhanced collagen and elastin production, though its use in SA treatment has not been widely studied.Objective: To assess the safety and effectiveness of using autologous cultivated fibroblasts to treat stria alba.Materials and Methods: Fifteen individuals with stria alba were included in this investigation. The study met all ethical requirements for human research and was approved by the Faculty of Medicine's Research Ethical Committee at Ain Shams University. Every patient gave written consent after being fully informed about the treatment process, any adverse effects, and visual documentation. The patients received three sessions of intradermal injections of autologous fibroblast suspension spaced two weeks apart.Results: Stria width ranged from 4 to 17.4 mm before the fibroblast injection (mean: 8.18 ± 3.85 mm). Three months post-treatment, the width decreased to 2.9–14.8 mm (mean: 7.17 ± 3.26 mm), and remained similar at six months (2.9–14.8 mm, mean: 7.16 ± 3.27 mm). No significant change in stria width was observed (p = 0.062). However, histological analysis showed notable improvements in epidermal thickness, collagen organization, and elastic fiber content.Conclusion: Autologous cultured fibroblast injection appears to be a safe and potentially promising therapy for SA, especially in terms of histological and structural skin improvements. Further studies with larger sample sizes, longer follow-up, and possibly combination therapies are recommended to achieve more visible clinical results.

Fields of Study & Subjects

Dermatologic Treatments and Research Facial Rejuvenation and Surgery Techniques Systemic Sclerosis and Related Diseases

Publication details

Journal / source
IP Indian Journal of Clinical and Experimental Dermatology
Volume
12
Issue
1
Pages
112–125
Publication date
18 March 2026
Language
EN